Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
4 mg can help people with Attention Deficit Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at evaluate the safety of long-term administration of mainly high doses of EB-1020 over 52 weeks in pediatric ADHD patients for people with Attention-Deficit Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Attention-deficit/Hyperactivity Disorder or Adhd. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is recruiting in South Korea. It focuses on ADHD.
This study is recruiting in Norway. It focuses on ADHD.
This study is comparing Dyanavel XR with placebo for people with Fatigue, Attention Deficit Hyperactivity Disorder, or Attention Deficit Disorder. Participants receive Dyanavel XR or placebo and complete study visits and assessments.
This study is recruiting in Japan. It is testing EB-1020 for ADHD.
This study is looking at evaluate the efficacy of acupuncture as a treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6-12 years for people with Acupuncture, ADHD - Attention Deficit Disorder With Hyperactivity, Children, or Interview. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether tPBM（active） can help people with ADHD - Attention Deficit Disorder With Hyperactivity. Participants take part in tPBM（active） and complete follow-up assessments.
This study is recruiting in the United States. It focuses on ADHD.
This observational study is following people with Attention Deficit Hyperactivity Disorder, Behavior Hyperactive, or Behavior Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing Concerta with placebo for people with Adhd. Participants receive Concerta or placebo and complete study visits and assessments.
This study is comparing Methylphenidate with placebo for people with Attention Deficit Hyperactivity Disorder Combined. Participants receive Methylphenidate or placebo and complete study visits and assessments.
This study is recruiting in France. It focuses on ADHD.
This study is looking at whether questionnaires and follow-up can help people with Adhd or ADHD - Attention Deficit Disorder With Hyperactivity. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with Attention Deficit Disorder with Hyperactivity. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether cognitive behavioural therapy can help people with Attention Deficit Hyperactivity Disorder or Substance-related Disorder. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is recruiting in the United States. It focuses on ADHD.
This study is looking at whether a digital support tool can help people with Adhd. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing Placebo with placebo for people with ADHD or onset ADHD With mood conditions. Participants receive Placebo or placebo and complete study visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Attention Deficit Hyperactivity Disorder. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is recruiting in China. It focuses on ADHD.
This study is looking at evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD for people with Attention-Deficit/Hyperactivity Disorder. Participants receive 100mg SPN-812 or placebo and complete study visits and assessments.
This study is recruiting in Japan. It is testing EB-1020 for ADHD.
This study is looking at whether a digital support tool can help people with ADHD - Attention Deficit Disorder With Hyperactivity. Participants take part in a digital support tool and complete follow-up assessments.